However, COVID-19 vaccine-induced antibody responses are diminished relative to healthy controls in patients with IBD taking anti-TNF and JAK-inhibitor therapies, but not anti-integrin or thiopurine monotherapy, following two and three vaccine doses. Here, TNF is linked to inflammatory bowel disease.